Elcelyx Therapeutics, Inc.

Quick facts

Marketed products

• Met DR
• Met IR · Endocrinology / Diabetes
  Met IR is a formulation of metformin immediate-release that reduces hepatic glucose production and improves insulin sensitivity to lower blood glucose levels in type 2 diabetes.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Elcelyx Therapeutics, Inc. portfolio CI brief
• Elcelyx Therapeutics, Inc. pipeline updates RSS